XML 22 R6.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Deficit [Member]
Retained Deficit [Member]
Revision of Prior Period, Accounting Standards Update, Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Balance at Dec. 29, 2019   $ 389 $ 243 $ (3,412,649)   $ (3,742)
Balance (in shares) at Dec. 29, 2019   38,934,009        
Net income $ 491,296     491,296    
Dividends declared on common stock and equivalents       (122,183)    
Issuance and cancellation of stock awards, net (in shares)   35,210        
Tax payments for restricted stock upon vesting     (6,803)      
Tax payments for restricted stock upon vesting, (in shares)   (18,681)        
Purchases of common stock   $ (8) (43,524) (261,058)    
Purchases of common stock, (in shares)   (838,871)        
Exercises of stock options   $ 8 30,962      
Exercises of stock options, (in shares) 756,683 756,683        
Non-cash equity-based compensation expense     24,244      
Currency translation adjustment           1,318
Balance at Jan. 03, 2021   $ 389 5,122 (3,303,492)   (2,424)
Balance (Credit Losses Standard [Member]) at Jan. 03, 2021         $ 1,102  
Balance (in shares) at Jan. 03, 2021   38,868,350        
Net income $ 510,467     510,467    
Dividends declared on common stock and equivalents       (139,588)    
Issuance and cancellation of stock awards, net (in shares)   (1,994)        
Tax payments for restricted stock upon vesting     (6,820)      
Tax payments for restricted stock upon vesting, (in shares)   (14,826)        
Purchases of common stock   $ (30) (45,568) (1,275,304)    
Purchases of common stock, (in shares)   (2,912,558)        
Exercises of stock options   $ 2 19,680      
Exercises of stock options, (in shares) 199,301 199,301        
Non-cash equity-based compensation expense     28,670      
Other     (244)      
Currency translation adjustment           (396)
Balance at Jan. 02, 2022 $ (4,209,536) $ 361 840 (4,207,917)   (2,820)
Balance (in shares) at Jan. 02, 2022 36,138,273 36,138,273        
Net income $ 452,263     452,263    
Dividends declared on common stock and equivalents       (157,479)    
Issuance and cancellation of stock awards, net (in shares)   15,012        
Tax payments for restricted stock upon vesting     (10,349) (371)    
Tax payments for restricted stock upon vesting, (in shares)   (26,699)        
Purchases of common stock   $ (7) (12,819) (280,914)    
Purchases of common stock, (in shares)   (739,847)        
Exercises of stock options     3,312      
Exercises of stock options, (in shares) 32,979 32,979        
Non-cash equity-based compensation expense     28,709      
Currency translation adjustment           (1,874)
Balance at Jan. 01, 2023 $ (4,189,065) $ 354 $ 9,693 $ (4,194,418)   $ (4,694)
Balance (in shares) at Jan. 01, 2023 35,419,718 35,419,718